| 发明名称 | Phospholipid ether analogs as cancer-targeting drug vehicles | ||
| 摘要 | The present invention is directed to therapeutic compounds capable of targeting cancer cells and cancer stem cells. The present invention is further directed to compositions comprising these therapeutic compounds and methods of treating cancer comprising administering these therapeutic compounds. | ||
| 申请公布号 | US9480754(B2) | 申请公布日期 | 2016.11.01 |
| 申请号 | US201615099789 | 申请日期 | 2016.04.15 |
| 申请人 | CELLECTAR BIOSCIENCES, INC. | 发明人 | Weichert Jamey P.;Pinchuk Anatoly;Kozak Kevin;Longino Marc;Grudzinski Joseph;Titz Benjamin;Pak Chorom;Stehle Nathan |
| 分类号 | A61K31/337;A61K47/48;A61K31/665;A61K31/395;A61K31/537;A61K31/00 | 主分类号 | A61K31/337 |
| 代理机构 | Wood, Phillips, Katz, Clark & Mortimer | 代理人 | Wood, Phillips, Katz, Clark & Mortimer |
| 主权项 | 1. A method of treating breast cancer, lung cancer, pancreatic cancer, colorectal cancer, and/or prostate cancer comprising administering an effective amount of a therapeutic compound of Formula (V),to a subject with cancer. | ||
| 地址 | Madison WI US | ||